Mercator Medical S.A. (WSE:MRC)

Mercator Medical Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	126.04	123.15	217.33	223.34	339.61	399.84
Short-Term Investments	86.78	126.96	109.53	198.46	195.7	147.32
Cash & Short-Term Investments	212.81	250.11	326.86	421.8	535.3	547.16
Cash Growth	-39.49%	-23.48%	-22.51%	-21.20%	-2.17%	3601.26%
Accounts Receivable	95.23	91.86	61.17	49.97	99.27	97.13
Other Receivables	23.72	23.76	42.51	19.54	25.32	19.28
Receivables	172.95	168.72	104.11	69.92	124.6	116.42
Inventory	234.23	214.65	153.09	204.67	253.36	429.6
Prepaid Expenses	0.29	0.49	0.52	0.45	0.56	0.43
Other Current Assets	0.82	0.7	0.66	0.72	0.35	1.92
Total Current Assets	621.1	634.67	585.24	697.56	914.17	1,096
Property, Plant & Equipment	298.3	310.79	251.66	281.96	334.65	183.41
Long-Term Investments	5.56	5.63	2.01	0.73	-	-
Other Intangible Assets	30.68	31.75	33.14	24.11	9.65	3.87
Long-Term Deferred Tax Assets	30.65	29.85	24.16	29.7	28.38	6.49
Other Long-Term Assets	10.28	10.78	2.96	4.05	1.68	0.02
Total Assets	1,017	1,043	965.23	1,083	1,289	1,289
Accounts Payable	67.35	77.29	53.49	35.8	62.41	100.58
Accrued Expenses	7.78	10.1	9.61	12.85	16.03	22.81
Short-Term Debt	0.06	0.05	0.15	0.21	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.69
Current Portion of Leases	1.24	1.44	0.85	0.72	1.31	1.54
Current Income Taxes Payable	2.69	2.4	4.24	0.03	24.61	89.42
Current Unearned Revenue	0.66	0.2	0.63	3.1	27.72	23.56
Other Current Liabilities	7.03	5.4	9.51	7.25	0.97	1.31
Total Current Liabilities	86.81	96.87	78.47	59.96	133.05	239.89
Long-Term Leases	3.38	3.07	4.41	2.46	3.52	2.02
Long-Term Unearned Revenue	-	-	0.15	0.16	0.16	0.17
Long-Term Deferred Tax Liabilities	6.72	15.78	20.87	8.54	4.35	2.96
Other Long-Term Liabilities	2.52	2.55	1.61	2.73	2.23	1.13
Total Liabilities	99.43	118.28	105.52	73.85	143.32	246.17
Common Stock	9.77	9.77	10.65	10.65	10.65	10.6
Additional Paid-In Capital	30.74	30.74	30.74	57.84	57.84	57.14
Retained Earnings	925.32	895.17	854.82	888.22	1,079	963.76
Comprehensive Income & Other	-44.96	-7.36	-34.12	52.02	-3.28	8.45
Total Common Equity	920.87	928.32	862.09	1,009	1,144	1,040
Minority Interest	-3.04	-3.16	-2.38	0.49	1.36	3.18
Shareholders' Equity	917.83	925.16	859.71	1,009	1,145	1,043
Total Liabilities & Equity	1,017	1,043	965.23	1,083	1,289	1,289
Total Debt	4.68	4.56	5.41	3.39	4.83	4.25
Net Cash (Debt)	208.13	245.55	321.45	418.41	530.47	542.91
Net Cash Growth	-39.95%	-23.61%	-23.17%	-21.12%	-2.29%	-
Net Cash Per Share	22.25	26.15	33.54	42.82	52.41	51.56
Filing Date Shares Outstanding	9.77	9.77	9.77	10.65	10.65	10.41
Total Common Shares Outstanding	9.77	9.77	9.42	10.65	10.65	10.41
Working Capital	534.28	537.8	506.76	637.6	781.12	855.63
Book Value Per Share	94.25	95.01	91.54	94.74	107.43	99.92
Tangible Book Value	890.18	896.57	828.95	984.62	1,134	1,036
Tangible Book Value Per Share	91.11	91.76	88.02	92.48	106.53	99.55
Land	-	45.99	41.8	47.24	51.94	8.78
Buildings	-	118.6	100.87	110.96	79.99	74.45
Machinery	-	274.18	223.41	201.74	172.21	170.27
Construction In Progress	-	5.68	1.07	32.75	115.12	4.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.